precision is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-02-04. Numbers and descriptions here follow the published literature rather than marketing material.
High-performance liquid chromatography is an analytical technique that separates components in a liquid sample by passing them through a packed column under pressure. A pump delivers a mobile phase at a controlled flow rate, and an injector introduces the sample into the stream. Differences in how analytes partition between the mobile phase and the stationary phase cause them to exit the column at different times. Detection then records a signal proportional to the amount of each separated substance. The resulting chromatogram provides retention times and peak areas for identification and quantification.
Instrumentation includes a solvent delivery system, an autosampler, a column oven, and one or more detectors. Reversed-phase columns with chemically modified silica are widely used, but normal-phase, ion-exchange, size-exclusion, and affinity modes exist for specific separations. Detectors may rely on ultraviolet absorbance, fluorescence, refractive index, or mass spectrometry. Column temperature, mobile phase composition, and flow rate are adjusted to improve resolution. System pressure is monitored because rising pressure can indicate column blockage or deteriorating packing.
Validation establishes that a method is suitable for its intended purpose. Typical parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantification, robustness, and stability of standards and samples. Acceptance criteria are defined in advance, and results are documented in a validation report. Regulatory guidance for pharmaceuticals, foods, and environmental testing differs, so the applicable framework must be identified. Ongoing verification uses control samples and trend charts after validation. Method transfer to another laboratory may require partial revalidation.
Routine quality control includes blanks, duplicates, spiked samples, and certified reference materials. Calibration curves are prepared with standards at several concentrations, and the detector response is checked for linearity. Carryover, column aging, mobile phase evaporation, and temperature drift can shift retention times or peak areas. Maintenance such as replacing seals, filters, and columns helps prevent failures. Records of injections, integration, and deviations support traceability. Audits may request raw data and instrument logs for each batch.
Developing an HPLC test begins with defining the analytes, matrix, and required reporting limits. Chemists select a separation mode, column chemistry, mobile phase composition, flow rate, and detection wavelength or mass transition. Experiments then adjust these variables to achieve adequate retention, resolution, and peak shape. System suitability tests confirm that the instrument and method perform consistently before sample analysis. Without suitable resolution, quantitative results may be unreliable. Preliminary runs often use scouting gradients to locate retention windows.
| Property | Value | Notes |
|---|---|---|
| Separation principle | Differential partitioning | Analytes distribute between mobile and stationary phases. |
| Mobile phase | Liquid solvent mixture | Composition controls retention and selectivity. |
| Stationary phase | Packed column particles | Often chemically bonded silica. |
| Typical detector | UV-Vis or photodiode array | Mass spectrometry is also common. |
| Common synonym | High-performance liquid chromatography | Abbreviated as HPLC. |
HPLC testing is an analytical technique used to separate, identify, and quantify components in a liquid sample. It relies on a pressurized mobile phase that carries the sample through a column packed with stationary phase. Different compounds travel at different rates because of interactions with the stationary and mobile phases. The resulting signal versus time is a chromatogram. Peak position indicates identity under specified conditions, while peak area or height relates to amount.
Laboratories apply HPLC testing across pharmaceutical, food, environmental, and industrial chemistry. The method can measure active ingredients, impurities, additives, preservatives, and degradation products. Sample preparation often includes dilution, filtration, and sometimes extraction or derivatization. The choice of column, mobile phase, pH, temperature, and detector depends on the analytes and matrix. Results are compared with reference standards to assign identity and concentration. Method suitability is judged by resolution, precision, and accuracy.
HPLC testing is not a single fixed procedure; it is a family of separation modes. Reversed-phase, normal-phase, ion-exchange, size-exclusion, and affinity chromatography each suit different analyte properties. Reversed-phase methods dominate because they handle many neutral and moderately polar compounds. Detection can be optical, electrochemical, or mass spectrometric, and the detector dictates what information is available. Coupling with mass spectrometry increases selectivity and enables identification when standards are unavailable. The technique cannot separate every mixture without adjustment.
Validation demonstrates that a method is suitable for its intended use. Typical performance characteristics include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Regulators and standards organizations provide frameworks, but specific requirements depend on the application and jurisdiction. System suitability tests are run before sample analysis to confirm resolution, peak symmetry, retention time repeatability, and sensitivity. A validated method is not permanently fixed; changes may require partial or full revalidation.
Routine HPLC testing depends on controlled reagents, calibrated instruments, and documented procedures. Columns degrade over time, so retention times and peak shapes are monitored for drift. Mobile phases are filtered and degassed to prevent pump damage and detector noise. Reference standards must be traceable and stored under suitable conditions. Data handling systems record injections, calculations, and audit trails. Quality control samples interspersed with unknowns help detect errors during a run.
Developing an HPLC method begins with defining the purpose, such as quantifying a main component, measuring impurities, or confirming identity. Analysts select separation mode, column, mobile phase, detection, and sample preparation based on analyte properties and matrix. Experiments vary solvent strength, pH, buffer type, and temperature to achieve resolution between critical peaks. The goal is a robust method that produces reliable results across instruments and operators. Method development often involves trial runs and statistical optimization.
HPLC testing separates dissolved compounds by passing a liquid sample through a column packed with stationary phase. A pump delivers mobile phase at controlled flow, and the sample components interact differently with stationary and mobile phases. Compounds that spend more time in mobile phase elute earlier; those retained by stationary phase elute later. Detectors record elution as peaks, and peak area or height relates to amount. This mechanism underpins quantitative analysis of mixtures.
Most routine HPLC testing uses reversed-phase columns, where the stationary phase is nonpolar and the mobile phase is a polar mixture such as water with an organic solvent. Analytes partition between the two phases according to polarity, size, and charge. Gradients that change solvent composition over time can separate compounds with broad retention ranges. Isocratic conditions keep solvent composition constant and suit simpler mixtures. The choice of column chemistry, pH, and temperature affects selectivity and peak shape.
Detection in HPLC testing commonly relies on ultraviolet-visible absorbance, fluorescence, refractive index, or mass spectrometry. UV detection is widely used because many organic compounds absorb light, but it requires a chromophore. Mass spectrometry provides mass-based identification and high sensitivity for trace analytes. Each detector has trade-offs in selectivity, cost, and compatibility with mobile phases. Quantification typically uses calibration curves prepared from reference standards. Results are reported as concentration, purity, or presence above a limit.
In quality control laboratories, HPLC testing supports batch release, raw material checks, stability studies, and impurity profiling. A validated method defines sample preparation, instrument settings, calibration, and acceptance criteria. Analysts compare results with specifications and investigate out-of-specification outcomes before a batch is approved. Documentation includes chromatograms, integration records, audit trails, and reagent details. Because results influence product decisions, laboratories follow formal quality systems and data integrity rules. The exact tests and limits depend on the material, its intended use, and the applicable regulatory framework.
Method validation examines whether an HPLC procedure is suitable for its intended purpose. Common parameters include accuracy, precision, specificity, linearity, range, detection limit, quantification limit, and robustness. Accuracy describes closeness to a true or accepted value, while precision describes agreement among repeated measurements. Specificity shows whether the method can measure the analyte without interference from related substances. Robustness tests small deliberate changes in flow, temperature, or solvent composition. Validation is not a one-time event; methods may need partial revalidation after changes to instruments, columns, sample handling, or specification limits. Regulatory guidance provides frameworks, but some details remain method-specific.
Regulatory and pharmacopeial texts shape how HPLC testing is performed and documented. The International Council for Harmonisation provides validation guidance, while pharmacopeias publish general chromatography chapters and monographs for specific materials. Accreditation standards such as ISO/IEC 17025 address laboratory competence and traceability. Inspectors may review instrument qualification, analyst training, reference material control, and electronic records. Open questions include how best to validate methods for new complex products and how to handle automated data processing. Laboratories generally resolve these issues through risk assessment, method lifecycle management, and documented scientific justification.
==== 1.G Viral fusion pores ==== 1.G.1 The Viral Pore-forming Membrane Fusion Protein-1 (VMFP1) Family 1.G.2 The Viral Pore-forming Membrane Fusion Protein-2 (VMFP2) Family 1.G.3 The Viral Pore-forming Membrane Fusion Protein-3 (VMFP3) Family 1.G.4 The Viral Pore-forming Membrane Fusion Protein-4 (VMFP4) Family 1.G.5 The Viral Pore-forming Membrane Fusion Protein-5 (VMFP5) Family 1.G.6 The Hepadnaviral S Fusion Protein (HBV-S Protein) Family 1.G.7 The Reovirus FAST Fusion Protein (R-FAST) Family 1.G.8 The Arenavirus Fusion Protein (AV-FP) Family 1.G.9 The Syncytin (Syncytin) Family 1.G.10 The Herpes Simplex Virus Membrane Fusion Complex (HSV-MFC) Family 1.G.11 Poxvirus Cell Entry Protein Complex (PEP-C) Family 1.G.12 The Avian Leukosis Virus gp95 Fusion Protein (ALV-gp95) Family 1.G.13 The Orthoreovirus Fusion-associated Small Transmembrane (FAST) Family 1.G.14 The Influenza Virus Hemagglutinin/Fusion Pore-forming Protein (Influenza-H/FPP) Family 1.G.15 The Autographa californica Nuclear Polyhedrosis Virus Major Envelope Glycoprotein GP64 (GP64) Family 1.G.16 The Human Immunodeficiency Virus Type 1 (HIV-1) Fusion Peptide (HIV-FP) Family 1.G.17 The Bovine Leukemia Virus Envelop Glycoprotein (BLV-Env) Family 1.G.18 The SARS-CoV Fusion Peptide in the Spike Glycoprotein Precursor (SARS-FP) Family 1.G.19 The Rotavirus Pore-forming Membrane Fusion Complex (Rotavirus MFC) Family 1.G.20 The Hantavirus Gc Envelope Fusion Glycoprotein (Gc-EFG) Family 1.G.21 The Epstein Barr Virus (Human Herpes Virus 4) Gp42 (Gp42) Family 1.G.22 The Cytomegalovirus (Human Herpesvirus 5) Glycoprotein gO (gO) Family
Tityustoxin peptide 2 (TsPep2) is a peptide isolated from the venom of the Tityus serrulatus (Brazilian yellow scorpion). It belongs to a class of short peptides, together with Tityustoxin peptide 1 and Tityustoxin peptide 3.
Acute erythema nodosum Bowel-associated dermatosis–arthritis syndrome (bowel bypass syndrome, bowel bypass syndrome without bowel bypass, intestinal bypass arthritis–dermatitis syndrome) Marshall syndrome Neutrophilic dermatosis of the dorsal hands (pustular vasculitis of the dorsal hands) Neutrophilic eccrine hidradenitis Pyoderma gangrenosum Pyogenic arthritis–pyoderma gangrenosum–acne syndrome (PAPA syndrome) Rheumatoid neutrophilic dermatitis (rheumatoid neutrophilic dermatosis) Superficial granulomatous pyoderma Sweet's syndrome (acute febrile neutrophilic dermatosis) Sweet's syndrome-like dermatosis Vesicopustular dermatosis
Individual variation within any racial group spans over 7 cm (3 inches) in some datasets, a range that is 15 to 30 times greater than the alleged average differences between racial groups, which typically measure less than 0.5 cm (0.2 inches) in clinician-measured studies. Factually race is therefore a poor predictor of any individual's penis size, and reported racial averages do not account for the substantial overlap between group distributions.
Sources: en.wikipedia.org
==== Developmental disorders ==== Hypospadias is a developmental disorder where the meatus is positioned wrongly at birth. Hypospadias can also occur iatrogenically by the downward pressure of an indwelling urethral catheter. It is usually corrected by surgery. A micropenis is a very small penis caused by developmental or congenital problems. Diphallia, or penile duplication (PD), is the rare condition of having two penises.
20 August – 2024 Ulster Unionist Party leadership election: Nominations open to elect the next leader of the Ulster Unionist Party. 21 August – 2024 Ulster Unionist Party leadership election: Doug Beattie rules himself out of running for re-election as UUP leader. 22–23 August – 2024 United Kingdom general election betting scandal: The Metropolitan Police ends its investigation into the betting scandal, saying that the offences being investigated have not met the "high bar" to prove misconduct in public office. The matter remains under investigation by the Gambling Commission. The UK government authorises the Infected Blood Compensation Authority to begin making payments to affected patients. 26 August – Keir Starmer cancels the appointment of Gwyn Jenkins as national security adviser. Questions are raised over Waheed Alli and his temporary pass to Number 10. 27 August – Keir Starmer delivers his first major speech a speech since becoming prime minister, and warns that the October budget will be "painful". The UK government cancels a £40m helicopter contract agreed by former prime minister Rishi Sunak. The UK government announces an extra £10.5m of funding to prepare for new EU border checks, with major ports receiving extra funding to prepare for the changes. The Scottish Fiscal Commission (SFC) warns the SNP government that “difficult decisions” are needed to balance its budget. 28 August – Starmer meets with German chancellor Olaf Scholz in Berlin to discuss UK–EU relations, before attending the Paralympics opening ceremony in Paris.
"Alsos Digital Library for Nuclear Issues – Plutonium". Washington and Lee University. Archived from the original on February 3, 2009. Retrieved February 15, 2009. Sutcliffe, W. G.; et al. (1995). "A Perspective on the Dangers of Plutonium". Lawrence Livermore National Laboratory. Archived from the original on September 29, 2006. "Physical, Nuclear, and Chemical, Properties of Plutonium". IEER. 2005. Retrieved February 15, 2009. "A History of Plutonium". Los Alamos National Laboratory. Retrieved July 8, 2023. Bhadeshia, H. "Plutonium crystallography". Samuels, D. (2005). "End of the Plutonium Age". Discover Magazine. 26 (11). Pike, J.; Sherman, R. (2000). "Plutonium production". Federation of American Scientists. Archived from the original on February 3, 2009. Retrieved February 15, 2009. "Plutonium Manufacture and Fabrication". Ong, C. (1999). "World Plutonium Inventories". Nuclear Files.org. Archived from the original on August 5, 2014. Retrieved February 15, 2009. "Challenges in Plutonium Science". Los Alamos Science. I & II (26). 2000. Retrieved February 15, 2009. "Plutonium". Royal Society of Chemistry. Retrieved February 6, 2015. "Plutonium". The Periodic Table of Videos. University of Nottingham. Retrieved February 6, 2015. Plutonium Fuel Fabrication by Argonne National Laboratory on YouTube
Sources: en.wikipedia.org
HPLC separates and detects individual compounds in a liquid sample, producing peaks at characteristic retention times. Peak area or height can be used to estimate concentration when calibrated with known standards. It does not identify unknown compounds with certainty unless additional detectors or reference materials are used.
Pressure drives the liquid mobile phase through a column packed with small particles. Without pressure, flow would be very slow or stop because the packed bed resists liquid movement. Modern pumps maintain a steady flow despite the resistance.
A chromatogram is a plot of detector signal against time after sample injection. Each peak represents a compound or group of compounds eluting from the column. Retention time and peak area are the main measurements read from the plot.
System suitability is a set of checks performed before and during a run to confirm that the instrument, column, and method work as expected. Common checks include resolution, tailing factor, theoretical plates, and relative standard deviation of replicate injections. Failure triggers troubleshooting or method adjustment.